A comparison of proptosis reduction with teprotumumab versus surgical decompression based on fat-to-muscle ratio in thyroid eye disease

CONCLUSIONS: Baseline FMR can be used to counsel patients as to proptosis reduction with teprotumumab versus surgery. Subjects with low FMR obtain comparable proptosis reduction with teprotumumab or surgery, whereas high FMR is associated with more significant proptosis reduction following surgery over teprotumumab.PMID:37978819 | DOI:10.1080/01676830.2023.2282509
Source: Orbit - Category: Opthalmology Authors: Source Type: research
More News: Opthalmology | Study | Thyroid